Results indicated a positive trend in reducing fasting blood glucose, total cholesterol, and low-density lipoprotein cholesterol levels, with notable improvements in blood pressure control, particularly in patients with higher baseline blood pressure.
← all excerpts
Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease.
1
—
—